433 results on '"Fehse B"'
Search Results
2. Impact of molecular residual disease post allografting in myelofibrosis patients
3. Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma
4. Investigation of the mesenchymal stem cell compartment by means of a lentiviral barcode library
5. Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients
6. Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors
7. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
8. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis
9. Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
10. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
11. TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
12. Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication
13. Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
14. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
15. Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis
16. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
17. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors
18. Low frequency of calreticulin mutations in MDS patients
19. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HIV-POSITIVE PATIENTS WITH HIGH-RISK HEMATOLOGIC MALIGNANCIES: PH-AB265
20. Reduced proliferation of CD34+ cells from patients with acute myeloid leukemia after gene transfer of INPP5D
21. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
22. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM
23. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques
24. Insertional mutagenesis and clonal dominance: biological and statistical considerations
25. Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA
26. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations
27. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
28. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up
29. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
30. Self-inactivating retroviral vectors with improved RNA processing
31. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle
32. A novel ‘sort-suicide’ fusion gene vector for T cell manipulation
33. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell
34. The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro
35. CD34+-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation
36. Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency
37. Depletion of alloreactive donor T cells using immunomagnetic cell selection
38. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements
39. Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking
40. Introduction of differential KIR activation mediated patterns of NK cell cytotoxicity against myeloma: P884
41. Selected Abstract Utility of JAK2V617F and MPLW515L/K mutation analysis in the setting of allogeniec stem cell transplantation for myelofibrosis: V109
42. Purging and haemopoietic progenitor cell selection by CD34+ cell separation
43. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma: V298
44. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function
45. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma: O157
46. The priority of lymphoid reconstitution as a prognostic factor for the results of unrelated haematopoietic stem cell transplantation for different haematological malignancies
47. Pois(s)on – It's a Question of Dose…
48. Endogenously produced factor XI (FXI) contributes to hepatic cancer cell-induced coagulation activation.
49. Mesenchymal stem cells are able to stimulate alloreactive immune cells
50. Measuring aldehyde dehydrogenase activity for quality assessment of haematopoietic stem cell transplants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.